Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of dexmedetomidine on basal ganglia neuronal activity in Parkinson's disease
2016-002680-34Phase 4Completed
- Sponsor
- Clínica Universidad de Navarra
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in Parkinson's disease (PD), sponsored by Clínica Universidad de Navarra. Primary endpoint: Local field potentials under different dexmedetomidine doses. Started Aug 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2016-002680-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002680-34.